2019
DOI: 10.1002/2211-5463.12753
|View full text |Cite
|
Sign up to set email alerts
|

A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma

Abstract: Lung cancer is the leading cause of cancer‐related morbidity and mortality worldwide, with lung adenocarcinoma (LUAD) being the most common histological subtype (approximately 40%). In the absence of reliable screening biomarkers for early diagnosis, most patients with LUAD are inevitably diagnosed at an advanced stage. MicroRNAs (miRNAs) encapsulated within plasma‐derived extracellular vesicles (EVs) may be suitable for use as noninvasive diagnostic biomarkers for aggressive malignancies, including LUAD. In t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(17 citation statements)
references
References 44 publications
(68 reference statements)
0
13
0
Order By: Relevance
“…hsa-miR-451a has also been shown to have an association with lung cancer. Yao et al (41) demonstrated that hsa-miR-451a derived from extracellular vesicles was significantly increased in plasma of LUAD patients, compared to HCs, and was available for LUAD diagnosis. Especially mentioned, hsa-miR-451a was reported to play a key role in inhibiting the migration and invasion of NSCLC cells by regulating ATF2 expression (42).…”
Section: Discussionmentioning
confidence: 99%
“…hsa-miR-451a has also been shown to have an association with lung cancer. Yao et al (41) demonstrated that hsa-miR-451a derived from extracellular vesicles was significantly increased in plasma of LUAD patients, compared to HCs, and was available for LUAD diagnosis. Especially mentioned, hsa-miR-451a was reported to play a key role in inhibiting the migration and invasion of NSCLC cells by regulating ATF2 expression (42).…”
Section: Discussionmentioning
confidence: 99%
“… MicroRNA Target gene Sample Cancer Refs. ↑ miR-205–5p HSPA8; DNAJA1 Serum EV Ovarian [289] ↑ miR-214–3p HSP90AB1;HSPD1 Serum EV Ovarian [289] ↑ miR-214–5p HSPA2;HSPA14; BAG2 Serum EV Ovarian [289] ↑ miR-495–3p HSPA5; HSPA1B; HSP90AA1; DNAJC21 Plasma EV Lung [290] ↓ miR-411–5p DNAJB9;DNAJC10;ST13 Plasma EV Lung [290] ↓ miR-615–3p HSPA1B;HSPA4;CCT8;HSPA8;HSPA9;CCT1;HSP90AB1;DNAJA2;DNAJC9;DNAJC10; PPIF;CDC37;TRAP1;BAG6;BAG5;CCT7 Plasma EV ccRCC [291] ↑ miR-224–5p HSP90AA1 Serum EV ccRCC [292] ↑ miR-224–3p DNAJB4; DNAJC28 Serum EV ccRCC [292] ↑ miR-375 HSP90AA1;DNAJC8; DNAJC2 Urine EV Prostate [ 293 , 294 ] ↑ Let-7c-5p HSPA4;DNAJC6;DNAJC16; DNAJC28 Urine EV Prostate [294] ↑ Let-7c-3p DNAJB6; BAG4 Urine EV Prostate [294] ↓ miR-196a-5p HSPA4L; TRAP1 Urine EV Prostate [295] ↑ miR-326 HSPA1B …”
Section: Hsps and Micrornasmentioning
confidence: 99%
“…The GSE111803 dataset was based on GPL16791 Illumina HiSeq 2500, including ve serum exosome samples of lung adenocarcinoma and ve healthy controls. [11] The GSE90728 based on GPL16791Illumina HiSeq 2500 contained 36 NSCLC tissues and 32 adjacent lung tissue, and 27 LUAD tissues and 24 adjacent lung tissue were included in the present study.…”
Section: Microarray Datamentioning
confidence: 99%